Skip to main content
. 2016 Jul 12;115(3):290–296. doi: 10.1038/bjc.2016.209

Table 2. Selected non-haematologic and haematologic events treatment-related adverse events.

  Dose level 1 (n=3)
Dose level 2 (n=5)
Dose level 3 (n=16)
Adverse event No. % No. % No. %
Nausea
Grade 1 1 33 3 60 8 50
Grade 2 0   0   0  
Grade 3 0   0   1 6
Grade 4 0   0   0  
Vomiting
Grade 1 1 33 1 20 6 38
Grade 2 0   0   2 12
Grade 3 0   0   0  
Grade 4 0   0   0  
Fatigue
Grade 1 0   3 60 6 38
Grade 2 2 67 1 20 5 31
Grade 3 1 33 1 20 3 19
Grade 4 0   0   0  
Diarrhoea
Grade 1 1 33 1 20 2 12
Grade 2 1 33 1 20 3 19
Grade 3 0   1 20 0  
Grade 4 0   0   0  
Sensory neuropathy
Grade 1 1 33 1 20 8 50
Grade 2 1 33 1 20 2 12
Grade 3 0   0   0  
Grade 4 0   0   0  
Hand-foot syndrome
Grade 1 0   0   2 12
Grade 2 1 33 1 20 3 19
Grade 3 0   0   2 12
Grade 4 0   0   0  
Neutropenia
Grade 1 0   2 40 4 25
Grade 2 0   0   1 6
Grade 3 2 67 1 20 4 25
Grade 4 1 33 0   5 31
Anaemia
Grade 1 1 33 2 40 7 44
Grade 2 2 67 2 40 6 38
Grade 3 0   1 20 2 12
Grade 4 0   0   0  
Thrombocytopenia
Grade 1 2 67 2 40 6 38
Grade 2 1 33 1 20 4 25
Grade 3 0   0   0  
Grade 4 0   0   0  
Febrile neutropenia
Grade 1 0   0   0  
Grade 2 0   0   0  
Grade 3 0   0   1 6
Grade 4 0   0   0